1. Home
  2. VOR vs LZB Comparison

VOR vs LZB Comparison

Compare VOR & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$22.35

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo La-Z-Boy Incorporated

LZB

La-Z-Boy Incorporated

HOLD

Current Price

$30.68

Market Cap

1.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
VOR
LZB
Founded
2015
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
VOR
LZB
Price
$22.35
$30.68
Analyst Decision
Buy
Strong Buy
Analyst Count
10
1
Target Price
$45.33
$39.00
AVG Volume (30 Days)
697.7K
765.0K
Earning Date
05-11-2026
06-16-2026
Dividend Yield
N/A
2.75%
EPS Growth
N/A
5.11
EPS
N/A
N/A
Revenue
N/A
$2,349,433,000.00
Revenue This Year
N/A
$1.89
Revenue Next Year
N/A
$2.09
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.50
$29.03
52 Week High
$49.95
$44.90

Technical Indicators

Market Signals
Indicator
VOR
LZB
Relative Strength Index (RSI) 47.59 28.77
Support Level $21.90 N/A
Resistance Level $24.44 $40.42
Average True Range (ATR) 1.13 0.91
MACD -0.19 -0.09
Stochastic Oscillator 12.44 3.74

Price Performance

Historical Comparison
VOR
LZB

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

About LZB La-Z-Boy Incorporated

La-Z-Boy Inc is a world'wide producer of reclining chairs and one of the manufacturers/distributors of residential furniture in the United States. It manufacture, market, import, export, distribute and retail upholstery furniture products. In addition, it import, distribute and retail accessories and casegoods (wood) furniture products. Its reportable operating segments include the Retail segment and the Wholesale segment. Its Retail segment mainly sells upholstered furniture. Wholesale segment manufactures and imports upholstered and casegoods (wood) furniture and sells directly. The company generates majority of revenue from Wholesale segment which manufactures and imports upholstered furniture, such as recliners and motion furniture, sofas, loveseats, chairs, sectionals, modulars, etc.

Share on Social Networks: